New Year Bumper Sale @ Rs. 1 X
Lipicure CV Capsule is an allopathic medicine The correct dosage of Lipicure CV Capsule depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Lipicure CV Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Lipicure CV Capsule safe for pregnant women?
Lipicure CV Capsule can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Lipicure CV Capsule right away. Take your doctor's advice before taking it again.
Is the use of Lipicure CV Capsule safe during breastfeeding?
Side effects of Lipicure CV Capsule on breastfeeding women are very mild.
What is the effect of Lipicure CV Capsule on the Kidneys?
Lipicure CV Capsule may have mild side effects on the kidneys.
What is the effect of Lipicure CV Capsule on the Liver?
You may experience side effects on your liver after taking Lipicure CV Capsule. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Lipicure CV Capsule on the Heart?
Very few cases of side effects of Lipicure CV Capsule on the heart have been reported.
Lipicure CV Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lipicure CV Capsule unless your doctor advises you to do so -
Is this Lipicure CV Capsule habit forming or addictive?
Forming a habit of Lipicure CV Capsule has not been reported.
Interaction between Food and Lipicure CV Capsule
Lipicure CV Capsule may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Lipicure CV Capsule
Information about the interaction of Lipicure CV Capsule and alcohol is not currently available because this topic has not been researched yet.
Yes, Lipicure CV Capsule is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at regular doses such as confusion, diarrhea, joint pain, and muscle pain. Do not hesitate to inform your doctor if you are facing any of the above.
Lipicure CV Capsule comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
Yes, Lipicure CV Capsule can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking ibuprofen do not hesitate to inform your doctor.
Lipicure CV Capsule is a brand name of atorvastatin which belongs to the class of drugs known as statins (dyslipidemic agents). It is a prescription drug that is used for the treatment of mixed dyslipidemia (high levels of lipids in the blood), hypercholesterolemia (high cholesterol levels), and hypertriglyceridemia.
No, Lipicure CV Capsule is a prescription drug so do not take it without consulting a doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, patient should seek doctors advice before taking this medication by himself or herself.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336